These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8164850)

  • 1. ACh receptor in ocular MG.
    Horton RM; Conti-Tronconi BM; Manfredi AA
    Neurology; 1994 Apr; 44(4):778-9. PubMed ID: 8164850
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-mediated mechanisms of ACh receptor loss in myasthenia gravis: clinical relevance.
    Drachman DB; Adams RN; Josifek LF; Pestronk A; Stanley EF
    Ann N Y Acad Sci; 1981; 377():175-88. PubMed ID: 6951471
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis. II. Histochemical demonstration of acetylcholinesterase activity in motor end-plates of extraocular muscle in patients with myasthenia gravis; a post-mortem study.
    COHEN RB; ZACKS SI
    Am J Pathol; 1959; 35(2):399-405. PubMed ID: 13627134
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylcholine receptor epitopes in ocular myasthenia.
    Kaminski HJ
    Ann N Y Acad Sci; 1998 May; 841():309-19. PubMed ID: 9668249
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effector-receptors relationship: acetylcholine and myasthenia gravis].
    Matsuda T; Takeyasu K; Yoshida H
    Nihon Rinsho; 1979; 37(8):3125-30. PubMed ID: 390184
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylcholine in intercostal muscle from myasthenia gravis patients and in rat diaphragm after blockade of acetylcholine receptors.
    Molenaar PC; Polak RL; Miledi R; Alema S; Vincent A; Newsom-Davis J
    Prog Brain Res; 1979; 49():449-58. PubMed ID: 515442
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular myasthenia gravis and chronic inflammatory polyradiculoneuropathy.
    Weinreb H; Klein J; Kupersmith M
    N Y State J Med; 1986 Aug; 86(8):439-42. PubMed ID: 3463893
    [No Abstract]   [Full Text] [Related]  

  • 9. Why are eye muscles frequently involved in myasthenia gravis?
    Kaminski HJ; Maas E; Spiegel P; Ruff RL
    Neurology; 1990 Nov; 40(11):1663-9. PubMed ID: 1700335
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to pathohistology of the extrinsic ocular muscles in myasthenia gravis pseudoparalytica (author's transl)].
    Remus I; Lahl R
    Klin Monbl Augenheilkd; 1974 Jun; 164(6):776-83. PubMed ID: 4138873
    [No Abstract]   [Full Text] [Related]  

  • 11. MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient.
    Ragunathan K; Pathak B; Dahal K
    J Neurol; 2015 Mar; 262(3):777-8. PubMed ID: 25588730
    [No Abstract]   [Full Text] [Related]  

  • 12. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered isotope charge distribution of acetylcholine neurotransmitter and Myasthenia Gravis.
    Bayri A; Unal S; Altin S; Bulut F; Dayanc BE
    Med Hypotheses; 2016 Apr; 89():84-8. PubMed ID: 26968916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of diagnostic tests in myasthenia gravis.
    Nicholson GA; McLeod JG; Griffiths LR
    Clin Exp Neurol; 1983; 19():45-9. PubMed ID: 6568927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholine receptor turnover in myasthenia gravis.
    Appel SH; Blosser JC; McManaman JL; Ashizawa T
    Am J Physiol; 1982 Jul; 243(1):E31-6. PubMed ID: 7091363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoidosis in a case of MuSK-positive myasthenia gravis.
    Spengos K; Vassilopoulou S; Christou Y; Manta P
    Neuromuscul Disord; 2008 Nov; 18(11):890-1. PubMed ID: 18815037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prepubertal muscle-specific kinase myasthenia with a long and benign natural course.
    Zouvelou V; Velonakis G
    Muscle Nerve; 2016 Jun; 53(6):989. PubMed ID: 26663151
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation.
    Losen M; Martínez-Martínez P; Phernambucq M; Schuurman J; Parren PW; De Baets MH
    Ann N Y Acad Sci; 2008; 1132():174-9. PubMed ID: 18567867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.